Efgartigimod for Guillain-Barré syndrome: rationale, clinical evidence, and future perspectives. Wang X, Song Y, He W, Tao X, Long E Front Immunol. 2026; 17:1952646. PMID: 42813052. Abstract CommentRecommendBookmarkWatch
